IL13RA1
Interleukin-13 receptor subunit alpha-1
Also known as: CD213a1, I13R1_HUMAN, IL-13Ra, NR4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P78552
- Gene
- IL13RA1
- Ensembl
- ENSG00000131724
- Chromosome
- X
- Canonical length
- 427 aa
- Protein class
- CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
The protein encoded by this gene is a subunit of the interleukin 13 receptor. This subunit forms a receptor complex with IL4 receptor alpha, a subunit shared by IL13 and IL4 receptors. This subunit serves as a primary IL13-binding subunit of the IL13 receptor, and may also be a component of IL4 receptors. This protein has been shown to bind tyrosine kinase TYK2, and thus may mediate the signaling processes that lead to the activation of JAK1, STAT3 and STAT6 induced by IL13 and IL4. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
427 residues, UniProt reviewed canonical sequence.
>P78552|IL13RA1
1 MEWPARLCGL WALLLCAGGG GGGGGAAPTE TQPPVTNLSV SVENLCTVIW TWNPPEGASS
61 NCSLWYFSHF GDKQDKKIAP ETRRSIEVPL NERICLQVGS QCSTNESEKP SILVEKCISP
121 PEGDPESAVT ELQCIWHNLS YMKCSWLPGR NTSPDTNYTL YYWHRSLEKI HQCENIFREG
181 QYFGCSFDLT KVKDSSFEQH SVQIMVKDNA GKIKPSFNIV PLTSRVKPDP PHIKNLSFHN
241 DDLYVQWENP QNFISRCLFY EVEVNNSQTE THNVFYVQEA KCENPEFERN VENTSCFMVP
301 GVLPDTLNTV RIRVKTNKLC YEDDKLWSNW SQEMSIGKKR NSTLYITMLL IVPVIVAGAI
361 IVLLLYLKRL KIIIFPPIPD PGKIFKEMFG DQNDDTLHWK KYDIYEKQTK EETDSVVLIE
421 NLKKASQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL13RA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 113 nTPM
Expression across tissuesHPA
Tissue
- liver: 113 nTPM
- rectum: 58 nTPM
- small intestine: 57 nTPM
- tongue: 52 nTPM
- ovary: 51 nTPM
- esophagus: 50 nTPM
Single-cell type
- esophageal apical cells: 543 nCPM
- neutrophils: 444 nCPM
- tuft cells: 323 nCPM
- microglia: 310 nCPM
- cdc: 279 nCPM
- macrophages: 222 nCPM
Immune cell
- neutrophil: 29 nTPM
- myeloid DC: 17 nTPM
- eosinophil: 12 nTPM
- classical monocyte: 11 nTPM
- memory B-cell: 2.9 nTPM
- plasmacytoid DC: 2.9 nTPM
Brain region
- medulla oblongata: 44 nTPM
- white matter: 40 nTPM
- hypothalamus: 36 nTPM
- spinal cord: 35 nTPM
- pons: 33 nTPM
- choroid plexus: 31 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 0.52
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway
- cytokine-mediated signaling pathway
- positive regulation of immunoglobulin production
Molecular functions
Cellular components
- external side of plasma membrane
- plasma membrane
- receptor complex
- interleukin-13 receptor complex
Protein domainsUniProt · Pfam · InterPro
- Short hematopoietin receptor, family 2, conserved site
- Fibronectin type III
- Immunoglobulin-like fold
- Type I cytokine receptor, cytokine-binding domain
- Fibronectin type III superfamily
- Interleukin-6 receptor alpha chain, binding
- Interleukin-13 receptor subunit alpha-1, Ig-like domain
- Interleukin-13 receptor subunit alpha Ig-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL13RA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL13RA1 as an antibody target. Whether an autoantibody or antibody against IL13RA1 could matter depends on whether native IL13RA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL13RA1 is annotated at the cell surface, where native IL13RA1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IL13RA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...